Author:
Kawai Hiromi,Tian Fengfeng,Kurata Tomoko,Deguchi Kentaro,Yamashita Toru,Omote Yoshio,Kono Syoichiro,Abe Koji
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Clinical Neurology,General Neuroscience
Reference44 articles.
1. Braunersreuther V, Mach F, Steffens S. The specific role of chemokines in atherosclerosis. Thromb Haemost. 2007;97(5):714–21.
2. Salminen A, Kaarniranta K. Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling. Cell Signal. 2010;22(4):573-7.
3. Kramsch DM, Sharma RC. Limits of lipid-lowering therapy: the benefits of amlodipine as an anti-atherosclerotic agent. J Hum Hypertens. 1995;9 Suppl 1:S3–9.
4. Thaulow E, Jorgensen B. Results and clinical implications of the CAPARES trial. Can J Cardiol. 2000;16(Suppl D):8D–11.
5. Li XQ, Cao W, Li T, Zeng AG, Hao LL, Zhang XN, et al. Amlodipine inhibits TNF-alpha production and attenuates cardiac dysfunction induced by lipopolysaccharide involving PI3K/Akt pathway. Int Immunopharmacol. 2009;9(9):1032–41.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献